Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor
Author(s) -
John A. Williams,
Robert Lim,
Paul Anantharajah Tambyah
Publication year - 2007
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2007.01.007
Subject(s) - bevacizumab , medicine , neutropenia , irinotecan , aspergillosis , chemotherapy , colorectal cancer , fluorouracil , folfiri , gastroenterology , vascular endothelial growth factor , oncology , cancer , surgery , immunology , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom